BMA - ICT Healthcare
Origio Benelux BV - Cooper Surgical Fertility & Genomic Solutions
Titus Healthcare BV
Trialbureau NVOG Consortium
BMA-ICT Healthcare verzorgt op donderdag 7 november 2019 twee keer een Wetenschappelijk Sessie in de Panoramalounge:
10:15 uur - 12:15 uur: Dystocia - Lacate in amniotic fluid. A new way to handle dystocic deliveries.
13:45 uur - 15:45 uur: Dystocia - Lacate in amniotic fluid. A new way to handle dystocic deliveries.
Spreker: Prof. Eva Wiberg-Itzel, Karolinska Institute Stockholm, Zweden
Eva Wiberg-Itzel currently works at the Department of Clinical Science and Education, Södersjukhuset, Karolinska Institute in Stockholm - Sweden. Eva does research in Obstetrics and their current project is 'Implementations project of AFL in clinical use'. Eva does research in clinical Obstetrics. Her current focus area is improving treatment of labor dystocia by measuring the level of lactate in amniotic fluid (AFL). Her main focus areas are: Labor dystocia, Prenatal diagnosis, Fetal surveillance during labor. Scientific background: The knowledge about lactate is a rapidly changing field, and our understanding of the role of lactate metabolism has changed dramatically from the classical views held in the 19th century. Prolonged labor is a risk factor for both mother and child through the increased risk of bleeding after childbirth, infections and fetal hypoxia. Also the risk of operative delivery increases with protracted labor. Substantial evidence show that a raised lactate level in the uterine muscle leads to inhibition of muscle contractions resulting in dysfunctional or arrested labor. The uterine lactate concentration is reflected in the lactate concentration in the amniotic fluid, which can be measured with a quick and non-invasive AFL (Amniotic Fluid Lactate) test. A normal AFL level is a strong indication that using oxytocin according to normal treatment protocols will result in a spontaneous vaginal delivery even if the labour has a slow progress. A high AFL level is a strong indication that using oxytocin will not improve the probability for a spontaneous vaginal delivery and that the delivery will end in operative intervention. However, by individualising the oxytocin infusion depending on the AFL level, the probability for an unnecessarily operative delivery can be avoided both if the AFL level is high and low.
Merck BV verzorgt op vrijdag 8 november 2019 een workshop: